GlassScriptPhysician profile
Divya U Sidhu
NPI 1124385547
$460.18
in general payments reported to CMS, 2019-2025
12 companies · $21.68 in 2025
The $21.68 reported for 2025 was less than what a typical Pediatrics provider received nationally (typical 2025 total: $96.93).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2022: $17.59 · 2023: $247 · 2024: $174 · 2025: $21.68.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $443.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $442.59 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Glaxosmithkline, LLC. | $77.03 | 2022-2024 | Bexsero, Rotarix, Pediarix |
| Pfizer INC. | $60.64 | 2023 | |
| Bayer Healthcare Pharmaceuticals INC. | $43.69 | 2023-2024 | |
| Aurinia Pharma U.S., INC. | $42.70 | 2023-2024 | Lupkynis |
| Cranial Technologies, INC | $36.88 | 2023-2024 | Doc Band |
| Alk-Abello, INC | $35.18 | 2024 | Grastek, Odactra |
| Novartis Pharmaceuticals Corporation | $35.01 | 2024 | |
| Nevro Corp. | $33.33 | 2023 | Senza |
| Lilly USA, LLC | $30.55 | 2023-2024 | Mounjaro, Jardiance |
| Otsuka America Pharmaceutical, INC. | $23.00 | 2023 | Jynarque |
| Sanofi Pasteur INC. | $21.68 | 2025 | |
| Seqirus USA INC | $20.49 | 2023 | Flucelvax Quadrivalent, Fluad Quadrivalent |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Divya Sidhu listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.